Chemical Compound

Tivozanib

CAS Registry Number 475108-18-0
Back to search Request a Quote
Tivozanib chemical structure
Primary Record

Tivozanib

In stock
7,366 g
Purity
98.4 %
CAS
475108-18-0

Compound Identifiers & Properties

CAS
475108-18-0
PubChem CID
9911830
SMILES
CC1=CC(=NO1)NC(=O)NC2=C(C=C(C=C2)OC3=C4C=C(C(=CC4=NC=C3)OC)OC)Cl
Canonical SMILES
COc1cc2nccc(Oc3ccc(NC(=O)Nc4cc(C)on4)c(Cl)c3)c2cc1OC

Names & Synonyms

  • Tivozanib
  • 475108-18-0
  • Tivozanib (AV-951)
  • fotivda
  • AV-951
  • tivozanibum
  • Tivozanib [USAN]
  • 4ase
  • KRN-951
  • AV951 Tivozanib
  • AV-951(Tivozanib)
  • AV-951,Tivozanib
  • AV951 cpd
  • Tivozanib [USAN:INN]
  • AV951
  • KRN951
  • C22H19ClN4O5
  • RefChem:58429
  • TIVOZANIB [INN]
  • Kil-8951
  • AV 951
  • Tivozanib (USAN/INN)
  • KIL8951
  • Tivozanib - AV-951
  • Tivozanib(AV-951)?
  • MFCD15146788
  • cc-12
  • D0W7JZ
  • KRN 951
  • TIVOZANIB [WHO-DD]
  • CHEMBL1289494
  • MLS006011287
  • SCHEMBL172883
  • DTXSID20963865
  • Tivozanib - Bio-X trade mark
  • GTPL6058
  • orb1305458
  • AV-951;KRN951
  • SCHEMBL29354238
  • SCHEMBL29354604
  • CHEBI:91327
  • KS-00001CTN
  • DTXCID60205690
  • EX-A472
  • L01XE34
  • SYN1013
  • SPMVMDHWKHCIDT-UHFFFAOYSA-N
  • Tivozanib hydrochloride monohydrate
  • UNII-172030934T
  • GLXC-90218
  • HMS3229O09
  • HMS3244C19
  • HMS3244C20
  • HMS3244D19
  • HMS3265A11
  • HMS3265A12
  • HMS3265B11
  • HMS3265B12
  • HMS3654G22
  • HMS3745C05
  • HMS5079O15
  • AMY39975
  • AOB87139
  • ASP-4130
  • BCP01980
  • ZINC1489430
  • ASP4130/AV-951
  • VEGFR Tyrosine Kinase Inhibitor IV
  • 1-(2-Chloro-4-((6,7-dimethoxyquinolin-4-yl)oxy)phenyl)-3-(5-methylisoxazol-3-yl)urea
  • ABP001003
  • AN-470
  • BDBM50331095
  • EBC-11349
  • NSC758007
  • NSC800952
  • RS0093
  • s1207
  • AKOS022177607
  • ACN-041317
  • BCP9000343
  • CCG-206805
  • CID9911830
  • CS-0103
  • DB11800
  • EX-8600
  • KRN 951 /TIVOZANIB/AV-951
  • NSC-758007
  • NSC-800952
  • PB28569
  • SDCCGSBI-0636568.P003
  • NCGC00249390-01
  • NCGC00249390-05
  • NCGC00249390-12
  • 4CA-1259
  • AC-24702
  • AJ-26332
  • AK-41796
  • AS-16997
  • BC659936
  • BP-44057
  • BT160380
  • BT300016
  • HY-10977
  • SC-54549
  • SMR004703037
  • SY122249
  • AB0007909
  • 172030934T
  • A2251
  • FT-0700315
  • N-[2-CHLORO-4-[(6,7-DIMETHOXY-4-QUINOLYL)OXY]PHENYL]-N'-(5-METHYL-3-ISOXAZOLYL)UREA
  • NS00068487
  • ST24037076
  • SW219364-1
  • X4932
  • J2.121.508B
  • A10101
  • A24970
  • D09683
  • Q-3811
  • 108K180
  • EN300-18167318
  • Q7810457
  • BRD-K53414658-001-01-7
  • BRD-K53414658-001-08-2
  • N-[2-Chloro-4-[(6,7-dimethoxy-4-quinolyl)oxy]pheny
  • 1-(2-CHLORO-4-(6,7-DIMETHOXYQUINOLIN-4-YLOXY)PHENYL)-3-(5-METHYLISOXAZOL-3-YL)UREA
  • 1-[2-chloro-4-(6,7-dimethoxyquinolin-4-yl)oxyphenyl]-3-(5-methyl-1,2-oxazol-3-yl)urea
  • 1-{2-chloro-4-[(6,7-dimethoxyquinolin-4-yl)oxy]phenyl}-3-(5-methyl-1,2-oxazol-3-yl)urea
  • AV951, AV-951, 475108-18-0
  • B2693-413727
  • Urea, N-(2-chloro-4-((6,7-dimethoxy-4-quinolinyl)oxy)phenyl)-N'-(5-methyl-3-isoxazolyl)-
  • Vascular Endothelial Growth Factor Receptor Tyrosine Kinase Inhibitor IV
  • 1-(2-Chloro-4-((6,7-dimethoxyquinolin-4-yl)-oxy)phenyl)-3-(5-methylisoxazol-3-yl)urea
  • 1-[2-chloro-4-[(6,7-dimethoxy-4-quinolyl)oxy]phenyl]-3-(5-methylisoxazol-3-yl)urea
  • N-(2-Chloro-4-((6,7-dimethoxy-4-quinolyl)oxy)phenyl)-N′-(5-methyl-3-isoxazolyl)urea
  • N-(2-Chloro-4-((6,7-dimethoxy-4-quinolyl)oxy)phenyl)-N'-(5-methyl-3-isoxazolyl)urea
  • 682745-41-1
  • 1-(2-chloro-4-((6,7-dimethoxyquinolin-4-yl)oxy)phenyl)-3-(5-methyl-1,2-oxazol-3-yl)urea
  • 1-[2-chloro-4-(6,7-dimethoxyquinolin-4-yl)oxy-phenyl]-3-(5-methyl-1,2-oxazol-3-yl)urea
  • 1-[2-chloro-4-[(6,7-dimethoxy-4-quinolinyl)oxy]phenyl]-3-(5-methyl-3-isoxazolyl)urea
  • 1-[2-Chloro-4-[(6,7-dimethoxyquinoline)-4-yloxy]phenyl]-3-(5-methylisoxazole-3-yl)urea
  • N-{2-Chloro-4-[(6,7-dimethoxy-4-quinolyl)-oxy]phenyl}-N'-(5-methyl-3-isoxazolyl)urea
  • N-{2-Chloro-4-[(6,7-dimethoxy-4-quinolyl)oxy]phenyl}-N'-(5-methyl-3-isoxazolyl)urea
  • 1-{2-chloro-4-[(6,7-dimethoxyquinolin-4-yl)oxy]phenyl}-3-[(3E)-5-methylisoxazol-3(2H)-ylidene]urea
  • 968-821-5
  • AV9
  • N-(2-CHLORO-4-((6,7-DIMETHOXYQUINOLIN-4-YL)OXY)PHENYL)-N'-(5-METHYLISOXAZOL-3-YL)UREA
  • N-{2-Chloro-4-[(6,7-dimethoxyquinolin-4-yl)oxy]phenyl}-N'-(5-methyl-1,2-oxazol-3-yl)urea
  • Urea, N-[2-chloro-4-[(6,7-dimethoxy-4-quinolinyl)oxy]phenyl]-N'-(5-methyl-3-isoxazolyl)-; N-[2-Chloro-4-[(6,7-dimethoxy-4-quinolinyl)oxy]phenyl]-N'-(5-methyl-3-isoxazolyl)urea; AV 951; KRN 951; Kil 8951; N-[2-Chloro-4-[(6,7-dimethoxy-4-quinolyl)oxy]phenyl]-N'-(5-methyl-3-isoxazolyl)urea; Tivozanib